• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

独特型-抗独特型Fab复合物的晶体学研究揭示登革病毒包膜糖蛋白的结构模拟

Structural Mimicry of the Dengue Virus Envelope Glycoprotein Revealed by the Crystallographic Study of an Idiotype-Anti-idiotype Fab Complex.

作者信息

Wong Yee Hwa, Goh Boon Chong, Lim She Yah, Teo En Wei, Lim Angeline P C, Dedon Pete C, Hanson Brendon J, MacAry Paul A, Lescar Julien

机构信息

Nanyang Institute for Structural Biology, School of Biological Sciences, Nanyang Technological University, Singapore, Singapore.

Singapore-MIT Alliance for Research and Technology, Singapore, Singapore.

出版信息

J Virol. 2017 Aug 10;91(17). doi: 10.1128/JVI.00406-17. Print 2017 Sep 1.

DOI:10.1128/JVI.00406-17
PMID:28637753
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5553163/
Abstract

A detailed understanding of the fine specificity of serotype-specific human antibodies is vital for the development and evaluation of new vaccines for pathogenic flaviviruses such as dengue virus (DENV) and Zika virus. In this study, we thoroughly characterize the structural footprint of an anti-idiotype antibody (E1) specific for a potent, fully human DENV serotype 1-specific antibody, termed HM14c10, derived from a recovered patient. The crystal structure at a resolution of 2.5 Å of a complex between the Fab fragments of E1 and HM14c10 provides the first detailed molecular comparison of an anti-idiotype paratope specific for a human antibody with its analogous epitope, a discontinuous quaternary structure located at the surface of the viral particle that spans adjacent envelope (E) proteins. This comparison reveals that the footprints left by E1 and E on HM14c10 largely overlap, explaining why the formation of binary complexes is mutually exclusive. Structural mimicry of the DENV E epitope by the E1 combining site is achieved via the formation of numerous interactions with heavy chain complementarity domain regions (CDRs) of HM14c10, while fewer interactions are observed with its light chain than for the E protein. We show that E1 can be utilized to detect HM14c10-like antibodies in sera from patients who recovered from DENV-1, infection suggesting that this is a public (common) idiotype. These data demonstrate the utility of employing an anti-idiotype antibody to monitor a patient's specific immune responses and suggest routes for the improvement of E "mimicry" by E1 by increasing its recognition of the Fab HM14c10 light chain CDRs. A chimeric yellow fever-dengue live-attenuated tetravalent vaccine is now being marketed. Dengue remains a significant public health problem, because protection conferred by this vaccine against the four circulating serotypes is uneven. Reliable tools must be developed to measure the immune responses of individuals exposed to DENV either via viral infection or through vaccination. Anti-idiotypic antibodies provide precision tools for analyzing the pharmacokinetics of antibodies in an immune response and also for measuring the amount of circulating anti-infective therapeutic antibodies. Here, we characterize how an anti-idiotypic antibody (E1) binds antibody HM14c10, which potently neutralizes DENV serotype 1. We report the crystal structure at a resolution of 2.5 Å of a complex between the Fab fragments of E1 and HM14c10 and provide the first detailed molecular comparison between the anti-idiotype surface and its analogous epitope located at the surface of the dengue virus particle.

摘要

深入了解血清型特异性人类抗体的精细特异性,对于开发和评估针对登革热病毒(DENV)和寨卡病毒等致病性黄病毒的新型疫苗至关重要。在本研究中,我们全面表征了一种抗独特型抗体(E1)的结构特征,该抗体特异性针对一种源自康复患者的强效、全人源DENV 1型特异性抗体,称为HM14c10。E1和HM14c10的Fab片段复合物分辨率为2.5 Å的晶体结构,首次详细比较了针对人类抗体的抗独特型互补决定区与其类似表位,该表位是位于病毒颗粒表面跨越相邻包膜(E)蛋白的不连续四级结构。这种比较表明,E1和E在HM14c10上留下的印记大部分重叠,解释了为何二元复合物的形成相互排斥。E1结合位点对DENV E表位的结构模拟是通过与HM14c10的重链互补决定区(CDR)形成众多相互作用实现的,而与轻链的相互作用比与E蛋白的少。我们表明,E1可用于检测DENV-1感染康复患者血清中类似HM14c10的抗体,表明这是一种公共(常见)独特型。这些数据证明了使用抗独特型抗体监测患者特异性免疫反应的实用性,并通过增加其对Fab HM14c10轻链CDR的识别,为改善E1对E的“模拟”提供了途径。一种嵌合黄热病 - 登革热减毒活四价疫苗目前正在上市。登革热仍然是一个重大的公共卫生问题,因为这种疫苗对四种流行血清型提供的保护并不均匀。必须开发可靠的工具来测量通过病毒感染或疫苗接种接触DENV的个体的免疫反应。抗独特型抗体为分析免疫反应中抗体的药代动力学以及测量循环中的抗感染治疗性抗体量提供了精确工具。在此,我们表征了抗独特型抗体(E1)如何结合能有效中和DENV 1型的抗体HM14c10。我们报告了E1和HM14c10的Fab片段复合物分辨率为2.5 Å的晶体结构,并首次详细比较了抗独特型表面与其位于登革热病毒颗粒表面的类似表位。

相似文献

1
Structural Mimicry of the Dengue Virus Envelope Glycoprotein Revealed by the Crystallographic Study of an Idiotype-Anti-idiotype Fab Complex.独特型-抗独特型Fab复合物的晶体学研究揭示登革病毒包膜糖蛋白的结构模拟
J Virol. 2017 Aug 10;91(17). doi: 10.1128/JVI.00406-17. Print 2017 Sep 1.
2
The structural basis for serotype-specific neutralization of dengue virus by a human antibody.人类抗体对登革热病毒血清型特异性中和作用的结构基础。
Sci Transl Med. 2012 Jun 20;4(139):139ra83. doi: 10.1126/scitranslmed.3003888.
3
Resistance analysis of an antibody that selectively inhibits dengue virus serotype-1.选择性抑制登革热病毒血清型-1的抗体的耐药性分析。
Antiviral Res. 2012 Sep;95(3):216-23. doi: 10.1016/j.antiviral.2012.06.010. Epub 2012 Jul 4.
4
An Envelope-Modified Tetravalent Dengue Virus-Like-Particle Vaccine Has Implications for Flavivirus Vaccine Design.一种经包膜修饰的四价登革病毒样颗粒疫苗对黄病毒疫苗设计具有启示意义。
J Virol. 2017 Nov 14;91(23). doi: 10.1128/JVI.01181-17. Print 2017 Dec 1.
5
Virus-like particles derived from Pichia pastoris-expressed dengue virus type 1 glycoprotein elicit homotypic virus-neutralizing envelope domain III-directed antibodies.源自毕赤酵母表达的1型登革病毒糖蛋白的病毒样颗粒可引发同型病毒中和性包膜结构域III导向抗体。
BMC Biotechnol. 2016 Jun 14;16(1):50. doi: 10.1186/s12896-016-0280-y.
6
Direct and indirect interactions in the recognition between a cross-neutralizing antibody and the four serotypes of dengue virus.一种交叉中和抗体与四种登革热病毒血清型之间识别过程中的直接和间接相互作用。
J Mol Recognit. 2014 Apr;27(4):205-14. doi: 10.1002/jmr.2352.
7
Epitope determinants of a chimpanzee Fab antibody that efficiently cross-neutralizes dengue type 1 and type 2 viruses map to inside and in close proximity to fusion loop of the dengue type 2 virus envelope glycoprotein.一种能有效交叉中和1型和2型登革热病毒的黑猩猩Fab抗体的表位决定簇定位于2型登革热病毒包膜糖蛋白融合环内部及附近。
J Virol. 2004 Dec;78(23):12919-28. doi: 10.1128/JVI.78.23.12919-12928.2004.
8
The immunogenicity of tetravalent dengue DNA vaccine in mice pre-exposed to Japanese encephalitis or Dengue virus antigens.四价登革热DNA疫苗对预先接触过日本脑炎或登革热病毒抗原的小鼠的免疫原性。
Asian Pac J Allergy Immunol. 2015 Sep;33(3):182-8. doi: 10.12932/AP0508.33.3.2015.
9
Development and characterization of serotype-specific monoclonal antibodies against the dengue virus-4 (DENV-4) non-structural protein (NS1).抗登革病毒 4 型(DENV-4)非结构蛋白(NS1)的血清型特异性单克隆抗体的研制与鉴定。
Virol J. 2018 Feb 6;15(1):30. doi: 10.1186/s12985-018-0925-7.
10
Chimpanzee Fab fragments and a derived humanized immunoglobulin G1 antibody that efficiently cross-neutralize dengue type 1 and type 2 viruses.黑猩猩Fab片段和一种衍生的人源化免疫球蛋白G1抗体,可有效交叉中和1型和2型登革热病毒。
J Virol. 2004 Dec;78(23):12910-8. doi: 10.1128/JVI.78.23.12910-12918.2004.

引用本文的文献

1
A novel strategy for an anti-idiotype vaccine: nanobody mimicking neutralization epitope of porcine circovirus type 2.一种新型抗独特型疫苗策略:纳米抗体模拟猪圆环病毒 2 型的中和表位。
J Virol. 2024 Feb 20;98(2):e0165023. doi: 10.1128/jvi.01650-23. Epub 2024 Jan 25.
2
Dengue virus neutralizing antibody: a review of targets, cross-reactivity, and antibody-dependent enhancement.登革病毒中和抗体:目标、交叉反应性和抗体依赖性增强的综述。
Front Immunol. 2023 Jun 2;14:1200195. doi: 10.3389/fimmu.2023.1200195. eCollection 2023.
3
Development of a structural epitope mimic: an idiotypic approach to HCV vaccine design.构建结构表位模拟物:丙型肝炎病毒疫苗设计的独特型方法
NPJ Vaccines. 2021 Jan 8;6(1):7. doi: 10.1038/s41541-020-00269-1.
4
Immune Modulatory Potential of Anti-idiotype Antibodies as a Surrogate of Foot-and-Mouth Disease Virus Antigen.抗独特型抗体的免疫调节潜力可作为口蹄疫病毒抗原的替代物。
mSphere. 2018 Oct 17;3(5):e00522-18. doi: 10.1128/mSphere.00522-18.
5
Modulation of Dengue/Zika Virus Pathogenicity by Antibody-Dependent Enhancement and Strategies to Protect Against Enhancement in Zika Virus Infection.抗体依赖性增强作用对登革热/寨卡病毒致病性的调节作用及寨卡病毒感染中预防增强作用的策略。
Front Immunol. 2018 Apr 23;9:597. doi: 10.3389/fimmu.2018.00597. eCollection 2018.
6
Development of Antibody Therapeutics against Flaviviruses.抗黄病毒抗体治疗药物的研发。
Int J Mol Sci. 2017 Dec 25;19(1):54. doi: 10.3390/ijms19010054.

本文引用的文献

1
The Impact of the Newly Licensed Dengue Vaccine in Endemic Countries.新获许可的登革热疫苗在流行国家的影响
PLoS Negl Trop Dis. 2016 Dec 21;10(12):e0005179. doi: 10.1371/journal.pntd.0005179. eCollection 2016 Dec.
2
Dissecting Antibodies Induced by a Chimeric Yellow Fever-Dengue, Live-Attenuated, Tetravalent Dengue Vaccine (CYD-TDV) in Naive and Dengue-Exposed Individuals.剖析由嵌合黄热病 - 登革热减毒活四价登革热疫苗(CYD - TDV)在未感染过登革热和曾感染过登革热的个体中诱导产生的抗体。
J Infect Dis. 2017 Feb 1;215(3):351-358. doi: 10.1093/infdis/jiw576.
3
Generation and Characterization of a Human/Mouse Chimeric GD2-Mimicking Anti-Idiotype Antibody Ganglidiximab for Active Immunotherapy against Neuroblastoma.用于神经母细胞瘤主动免疫治疗的人/鼠嵌合 GD2 模拟抗独特型抗体 Ganglidiximab 的制备和鉴定。
PLoS One. 2016 Mar 11;11(3):e0150479. doi: 10.1371/journal.pone.0150479. eCollection 2016.
4
The Molecular Engineering of an Anti-Idiotypic Antibody for Pharmacokinetic Analysis of a Fully Human Anti-Infective.用于全人源抗感染药物药代动力学分析的抗独特型抗体的分子工程
PLoS One. 2015 Dec 23;10(12):e0145381. doi: 10.1371/journal.pone.0145381. eCollection 2015.
5
A randomized, multicenter, placebo-controlled clinical trial of racotumomab-alum vaccine as switch maintenance therapy in advanced non-small cell lung cancer patients.一项随机、多中心、安慰剂对照的临床试验,评估 Racotumomab-alum 疫苗作为晚期非小细胞肺癌患者的转换维持治疗。
Clin Cancer Res. 2014 Jul 15;20(14):3660-71. doi: 10.1158/1078-0432.CCR-13-1674. Epub 2014 May 1.
6
Optimization of the additive CHARMM all-atom protein force field targeting improved sampling of the backbone φ, ψ and side-chain χ(1) and χ(2) dihedral angles.针对主链φ、ψ以及侧链χ(1)和χ(2)二面角改进采样的CHARMM全原子蛋白质加性力场的优化。
J Chem Theory Comput. 2012 Sep 11;8(9):3257-3273. doi: 10.1021/ct300400x. Epub 2012 Jul 18.
7
The structural basis for serotype-specific neutralization of dengue virus by a human antibody.人类抗体对登革热病毒血清型特异性中和作用的结构基础。
Sci Transl Med. 2012 Jun 20;4(139):139ra83. doi: 10.1126/scitranslmed.3003888.
8
Exploiting structure similarity in refinement: automated NCS and target-structure restraints in BUSTER.在精修中利用结构相似性:BUSTER中的自动非晶体学对称性及目标结构约束
Acta Crystallogr D Biol Crystallogr. 2012 Apr;68(Pt 4):368-80. doi: 10.1107/S0907444911056058. Epub 2012 Mar 16.
9
Overview of the CCP4 suite and current developments.CCP4软件包概述及当前进展
Acta Crystallogr D Biol Crystallogr. 2011 Apr;67(Pt 4):235-42. doi: 10.1107/S0907444910045749. Epub 2011 Mar 18.
10
Integration, scaling, space-group assignment and post-refinement.整合、缩放、空间群确定及后续精修。
Acta Crystallogr D Biol Crystallogr. 2010 Feb;66(Pt 2):133-44. doi: 10.1107/S0907444909047374. Epub 2010 Jan 22.